Car-T细胞疗法-话题@MedSci

#Car-T细胞疗法#

57篇内容 | 3752人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2213730, encodeId=739d2213e300b, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=918e1163562a' target=_blank style='color:#2F92EE;'>#TMIGD2#</a>, objectTitle=改良CAR-T细胞疗法！最新Science子刊研究：TOP CAR-T细胞疗法在实体瘤治疗领域获得重大突破, objectType=article, longId=833444, objectId=f154833444ed, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20240707/1720326449877_8827638.jpg, objectUrl=/article/show_article.do?id=f154833444ed, replyNumber=0, likeNumber=99, createdTime=2024-07-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208888, encodeId=9deb22088882c, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=da32115303b3' target=_blank style='color:#2F92EE;'>#儿童实体瘤#</a>, objectTitle=Nature子刊：新研究为儿童实体瘤挖掘潜在CAR-T疗法靶点, objectType=article, longId=827490, objectId=334182e490fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240607/1717774646038_5579292.png, objectUrl=/article/show_article.do?id=334182e490fd, replyNumber=0, likeNumber=101, createdTime=2024-06-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=334182e490fd, moduleTitle=Nature子刊：新研究为儿童实体瘤挖掘潜在CAR-T疗法靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=334182e490fd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208611, encodeId=489a22086118d, content=<a href='/topic/show?id=f6435e4216a' target=_blank style='color:#2F92EE;'>#放疗#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=大咖谈 | CAR-T细胞疗法和放疗联合的研究进展, objectType=article, longId=828410, objectId=5020828410ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717575626026_5579292.jpg, objectUrl=/article/show_article.do?id=5020828410ce, replyNumber=0, likeNumber=102, createdTime=2024-06-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5020828410ce, moduleTitle=大咖谈 | CAR-T细胞疗法和放疗联合的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5020828410ce)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207343, encodeId=b0cb220e34334, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=JCO：北京大学齐长松团队发现CAR-T细胞疗法让胰腺癌实体瘤患者获益, objectType=article, longId=827275, objectId=b2a782e27591, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240529/1716998037606_92910.jpg, objectUrl=/article/show_article.do?id=b2a782e27591, replyNumber=0, likeNumber=90, createdTime=2024-05-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b2a782e27591, moduleTitle=JCO：北京大学齐长松团队发现CAR-T细胞疗法让胰腺癌实体瘤患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a782e27591)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205846, encodeId=bd5b220584671, content=<a href='/topic/show?id=a8a58086451' target=_blank style='color:#2F92EE;'>#肉瘤#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=Nature Cancer：CAR-T细胞疗法为晚期肉瘤患者带来新希望, objectType=article, longId=825231, objectId=0c068252318b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716268577855_5579292.jpg, objectUrl=/article/show_article.do?id=0c068252318b, replyNumber=0, likeNumber=78, createdTime=2024-05-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0c068252318b, moduleTitle=Nature Cancer：CAR-T细胞疗法为晚期肉瘤患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c068252318b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194636, encodeId=d9342194636f9, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=01858406438' target=_blank style='color:#2F92EE;'>#胶质母细胞瘤#</a> <a href='/topic/show?id=6a1c60356fb' target=_blank style='color:#2F92EE;'>#替莫唑胺#</a>, objectTitle=NEJM：1期临床试验表明下一代CAR-T细胞疗法有望治疗复发性胶质母细胞瘤, objectType=article, longId=817139, objectId=2ca481e139b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240315/1710457355364_2185383.png, objectUrl=/article/show_article.do?id=2ca481e139b1, replyNumber=0, likeNumber=79, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190365, encodeId=011e2190365d6, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=f04c111e77b2' target=_blank style='color:#2F92EE;'>#弥漫性中线胶质瘤#</a>, objectTitle=Trends in Cancer：弥漫性中线胶质瘤的CAR-T细胞疗法综述, objectType=article, longId=812814, objectId=677c812814f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894905510_4754896.jpeg, objectUrl=/article/show_article.do?id=677c812814f8, replyNumber=0, likeNumber=83, createdTime=2024-03-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=677c812814f8, moduleTitle=Trends in Cancer：弥漫性中线胶质瘤的CAR-T细胞疗法综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677c812814f8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177721, encodeId=494c21e772153, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a> <a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, objectType=article, longId=807173, objectId=2efc80e17361, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231228/1703729896491_92910.png, objectUrl=/article/show_article.do?id=2efc80e17361, replyNumber=0, likeNumber=91, createdTime=2023-12-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2efc80e17361, moduleTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2efc80e17361)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177280, encodeId=31c121e728004, content=<a href='/topic/show?id=13db460162d' target=_blank style='color:#2F92EE;'>#实体瘤#</a> <a href='/topic/show?id=62f68635461' target=_blank style='color:#2F92EE;'>#自身免疫病#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=4e0a8933227' target=_blank style='color:#2F92EE;'>#血液系统肿瘤#</a>, objectTitle=打破“无药可治”局面！CAR-T疗法有望“治愈”多种疾病 | 年度医学进展盘点, objectType=article, longId=806981, objectId=f99180698194, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894905510_4754896.jpeg, objectUrl=/article/show_article.do?id=f99180698194, replyNumber=0, likeNumber=104, createdTime=2023-12-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f99180698194, moduleTitle=打破“无药可治”局面！CAR-T疗法有望“治愈”多种疾病 | 年度医学进展盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f99180698194)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176308, encodeId=4ddc21e630896, content=<a href='/topic/show?id=924442e98f' target=_blank style='color:#2F92EE;'>#CD19#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=febe1089e5e3' target=_blank style='color:#2F92EE;'>#AT101#</a>, objectTitle=Mol Cancer：1期临床试验表明一种新型CAR-T细胞疗法有望治疗B细胞非霍奇金淋巴瘤, objectType=article, longId=805123, objectId=1aec8051235f, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20231219/1702986161437_2185383.png, objectUrl=/article/show_article.do?id=1aec8051235f, replyNumber=0, likeNumber=82, createdTime=2023-12-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1291588, encodeId=2fe2129158857, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, objectType=article, longId=728112, objectId=d043e28112d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d043e28112d0, replyNumber=0, likeNumber=102, createdTime=2022-05-30, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d043e28112d0, moduleTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d043e28112d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291587, encodeId=ae35129158ed9, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=AACR 2022：BioNTech的CAR-T细胞疗法治疗实体瘤，疗效确切, objectType=article, longId=724120, objectId=4f46e241201a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f46e241201a, replyNumber=0, likeNumber=84, createdTime=2022-04-14, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f46e241201a, moduleTitle=AACR 2022：BioNTech的CAR-T细胞疗法治疗实体瘤，疗效确切, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f46e241201a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291586, encodeId=2f4a129158643, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤, objectType=article, longId=723516, objectId=7576e23516c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7576e23516c3, replyNumber=0, likeNumber=96, createdTime=2022-04-06, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7576e23516c3, moduleTitle=CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7576e23516c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291585, encodeId=3eec12915855b, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议, objectType=article, longId=301462, objectId=79c4301462ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79c4301462ab, replyNumber=0, likeNumber=83, createdTime=2022-03-24, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79c4301462ab, moduleTitle=FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79c4301462ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291584, encodeId=d99c12915848f, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=由于患者死亡，CAR-T细胞疗法ATA2271的临床试验被暂停, objectType=article, longId=299319, objectId=aae0299319f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aae0299319f3, replyNumber=0, likeNumber=91, createdTime=2022-02-23, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aae0299319f3, moduleTitle=由于患者死亡，CAR-T细胞疗法ATA2271的临床试验被暂停, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aae0299319f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291583, encodeId=de7912915838c, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=NEJM：CAR-T细胞疗法首次成功治疗红斑狼疮, objectType=article, longId=215829, objectId=75e621582978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75e621582978, replyNumber=0, likeNumber=87, createdTime=2021-08-18, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75e621582978, moduleTitle=NEJM：CAR-T细胞疗法首次成功治疗红斑狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75e621582978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291582, encodeId=a390129158230, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=Blood：糖皮质激素对CAR-T细胞疗法治疗的大B细胞淋巴瘤患者预后的影响, objectType=article, longId=212729, objectId=d16b212e29ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d16b212e29ab, replyNumber=0, likeNumber=93, createdTime=2021-06-16, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d16b212e29ab, moduleTitle=Blood：糖皮质激素对CAR-T细胞疗法治疗的大B细胞淋巴瘤患者预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d16b212e29ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291581, encodeId=986e1291581ca, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果, objectType=article, longId=211106, objectId=51f721110637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51f721110637, replyNumber=0, likeNumber=107, createdTime=2021-05-12, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51f721110637, moduleTitle=NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51f721110637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291580, encodeId=94c7129158044, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL, objectType=article, longId=210740, objectId=e5eb210e403b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5eb210e403b, replyNumber=0, likeNumber=67, createdTime=2021-05-03, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5eb210e403b, moduleTitle=Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5eb210e403b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1291579, encodeId=472812915e9be, content=<a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤, objectType=article, longId=209158, objectId=40ec209158b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40ec209158b9, replyNumber=0, likeNumber=88, createdTime=2021-03-31, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40ec209158b9, moduleTitle=日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40ec209158b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Car-T细胞疗法

2020-05-29

梅斯管理员

前往app查看评论内容

2024-07-07发表于上海

梅斯管理员

#Car-T细胞疗法# #儿童实体瘤#

Nature子刊：新研究为儿童实体瘤挖掘潜在CAR-T疗法靶点

2024-06-07发表于上海

梅斯管理员

#放疗# #Car-T细胞疗法#

大咖谈 | CAR-T细胞疗法和放疗联合的研究进展

2024-06-06发表于上海

梅斯管理员

#胰腺癌# #Car-T细胞疗法#

JCO：北京大学齐长松团队发现CAR-T细胞疗法让胰腺癌实体瘤患者获益

2024-05-30发表于上海

梅斯管理员

#肉瘤# #Car-T细胞疗法#

Nature Cancer：CAR-T细胞疗法为晚期肉瘤患者带来新希望

2024-05-21发表于上海

梅斯管理员

前往app查看评论内容

2024-03-22发表于上海

梅斯管理员

#Car-T细胞疗法# #弥漫性中线胶质瘤#

Trends in Cancer：弥漫性中线胶质瘤的CAR-T细胞疗法综述

2024-03-01发表于上海

梅斯管理员

#罕见病# #Car-T细胞疗法# #视神经脊髓炎谱系障碍# #获得性血友病A#

2023年度巨献：中国罕见病领域十大医学研究出炉

2023-12-28发表于上海

梅斯管理员

#实体瘤# #自身免疫病# #Car-T细胞疗法# #血液系统肿瘤#

打破“无药可治”局面！CAR-T疗法有望“治愈”多种疾病 | 年度医学进展盘点

2023-12-26发表于上海

梅斯管理员

前往app查看评论内容

2023-12-21发表于上海

changjitao2009

#Car-T细胞疗法#

Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效

2022-05-30

changjitao2009

#Car-T细胞疗法#

AACR 2022：BioNTech的CAR-T细胞疗法治疗实体瘤，疗效确切

2022-04-14

changjitao2009

#Car-T细胞疗法#

CAR-T细胞疗法Yescarta获得FDA批准用于早期治疗淋巴瘤

2022-04-06

changjitao2009

#Car-T细胞疗法#

FDA公布基因编辑与CAR-T细胞疗法两份指南草案，提出这些建议

2022-03-24

changjitao2009

#Car-T细胞疗法#

由于患者死亡，CAR-T细胞疗法ATA2271的临床试验被暂停

2022-02-23

changjitao2009

#Car-T细胞疗法#

NEJM：CAR-T细胞疗法首次成功治疗红斑狼疮

2021-08-18

changjitao2009

#Car-T细胞疗法#

Blood：糖皮质激素对CAR-T细胞疗法治疗的大B细胞淋巴瘤患者预后的影响

2021-06-16

changjitao2009

#Car-T细胞疗法#

NEJM：抗B细胞成熟抗原CAR-T细胞疗法bb2121治疗多发性骨髓瘤的效果

2021-05-12

changjitao2009

#Car-T细胞疗法#

Bone Marrow Transplant：供体源性抗CD19的CAR-T细胞疗法可安全有效的治疗异体造血干细胞移植后复发的B-ALL

2021-05-03

changjitao2009

#Car-T细胞疗法#

日本厚生劳动省批准CAR-T细胞疗法Breyanzi治疗DLBCL和滤泡性淋巴瘤

2021-03-31